content

Johnson & Johnson COVID-19 Vaccine Granted Authorization under Interim Order by Health Canada For Emergency Use

Johnson & Johnson announced that Health Canada has granted an Interim Order (IO) authorization for its single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical...

Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate

Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. announced initiation of study VLA15-221. The...

AARDEX and Schreiner MediPharm reinforce their collaboration to enhance Medication Adherence Management

AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical...

LSK Global PS Adopts Veeva Vault Clinical Applications to Streamline Global Trial Processes

Veeva Systems announced that LSK Global Pharma Services Co. Ltd, a leading Korean contract research organization (CRO), has adopted Veeva Vault eTMF, Veeva Vault...

Vetter establishes office in China to better serve the needs of its growing customer base worldwide

Germany based Vetter, one of the global leaders in prefilled drug-delivery systems, has announced the opening of a new business entity in Shanghai, China....

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a supply agreement with the Government of The Philippines for 13...

Natco’s marketing partner gets USFDA nod for cancer treatment drug

Natco Pharma said its marketing partner Breckenridge Pharmaceutical Inc has received final approval from the US health regulator for cancer treatment drug Everolimus. The...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read